Abuse liability of novel 'legal high' designer stimulants: evidence from animal models - PubMed (original) (raw)

Review

Lucas R Watterson et al. Behav Pharmacol. 2013 Sep.

Abstract

In the last few years, the variety and recreational use of 'legal high' designer stimulants has increased to unprecedented levels. Since their rapid emergence in drug markets, numerous adverse physical and psychological effects have been extensively reported. However, less is understood about the potential for compulsive use of and addiction to these drugs. Recently, a small collection of scientific studies assessing the abuse liability of these drugs has emerged. This new knowledge has been derived primarily from animal studies using behaviorally based procedures which include intravenous self-administration, conditioned place preference, intracranial self-stimulation, and drug discrimination. In this review we present a brief history of the recent rise in designer stimulant use followed by a short methodological description of the aforementioned procedures. We then review neurochemical and abuse liability studies on designer stimulants that have been examined to date. Finally, we conclude with a discussion of these collective findings, our current understanding of the abuse liability of these drugs in relation to each other and the illicit drugs they are designed to mimic, and recommend future research directions.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None declared

Similar articles

Cited by

References

    1. Aarde SM, Angrish D, Barlow DJ, Wright MJ Jr, Vandewater SA, Creehan KM, Houseknecht KL, Dickerson TJ, and Taffe MA (2013). Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats Addiction Biology, in press. - PMC - PubMed
    1. Aarde SM, Huang PK, Creehan KM, Dickerson TJ,Taffe MA (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats. Neuropharmacology 71:130–40. - PMC - PubMed
    1. Ahmed SH, and Koob GF. (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298–300. - PubMed
    1. Ahmed SH, and Koob GF (1999). Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology 146:303–12. - PubMed
    1. Ahmed SH (2010). Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction. Neuroscience and Biobehavioral Reviews 35:172–84. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources